Crestchem Limited (BOM:526269)
127.05
-3.95 (-3.02%)
At close: Jul 31, 2026
Crestchem Revenue
In the fiscal year ending March 31, 2026, Crestchem had annual revenue of 296.07M INR with 18.07% growth. Crestchem had revenue of 102.25M in the quarter ending March 31, 2026, with 41.39% growth.
Revenue
296.07M
Revenue Growth
+18.07%
P/S Ratio
1.29
Revenue / Employee
59.21M
Employees
5
Market Cap
381.15M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 296.07M | 45.30M | 18.07% |
| Mar 31, 2025 | 250.77M | 38.21M | 17.98% |
| Mar 31, 2024 | 212.56M | 45.28M | 27.07% |
| Mar 31, 2023 | 167.28M | 87.81M | 110.49% |
| Mar 31, 2022 | 79.47M | 3.06M | 4.00% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Supha Pharmachem | 5.27B |
| Smruthi Organics | 1.02B |
| Tyche Industries | 536.34M |
| Vasundhara Rasayans | 357.23M |
| Auro Laboratories | 307.40M |
| Link Pharma Chem | 274.32M |
| Krebs Biochemicals & Industries | 237.32M |
| Ishita Drugs and Industries | 146.60M |